CN106278915A - A kind of method preparing tapentadol hydrochloride intermediate - Google Patents

A kind of method preparing tapentadol hydrochloride intermediate Download PDF

Info

Publication number
CN106278915A
CN106278915A CN201510255379.5A CN201510255379A CN106278915A CN 106278915 A CN106278915 A CN 106278915A CN 201510255379 A CN201510255379 A CN 201510255379A CN 106278915 A CN106278915 A CN 106278915A
Authority
CN
China
Prior art keywords
compound
proline
reaction
meta
tartaric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510255379.5A
Other languages
Chinese (zh)
Inventor
李子清
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHONGQING CHANGJIE MEDICAL CHEMICAL Co Ltd
Chongqing Shenghuaxi Pharmaceutical Co Ltd
Original Assignee
CHONGQING CHANGJIE MEDICAL CHEMICAL Co Ltd
Chongqing Shenghuaxi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHONGQING CHANGJIE MEDICAL CHEMICAL Co Ltd, Chongqing Shenghuaxi Pharmaceutical Co Ltd filed Critical CHONGQING CHANGJIE MEDICAL CHEMICAL Co Ltd
Priority to CN201510255379.5A priority Critical patent/CN106278915A/en
Publication of CN106278915A publication Critical patent/CN106278915A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a kind of enantioselective synthesis method of tapentadol hydrochloride key intermediate.The present invention is with meta-methoxy propiophenone as initiation material, under the catalysis of chiral catalyst L-PROLINE, asymmetric mannich is occurred to react, generating (S)-3-(dimethylamino)-1-(3-methoxyphenyl)-2-methyl acetone, this compound is the key intermediate of synthetic hydrochloric acid tapentadol hydrochloride.The present invention has the advantages such as raw material availability is high, reaction condition is gentle, garbage is few.

Description

A kind of method preparing tapentadol hydrochloride intermediate
Technical field
The present invention relates to medication chemistry technology, prepare tapentadol hydrochloride key intermediate 2S-3-dimethylamino-1-(3-methoxyphenyl more specifically to one) synthesis technique of-2-methyl isophthalic acid-acetone.
Background technology
Tapentadol hydrochloride (tapentadol), chemistry entitled (-)-(1R, 2R)-3-(3-dimethylamino-1-Ethyl-2-Methyl propyl group) phenol hydrochloride, is by Gruenenthal company of Germany and Johson & Johnson (Johnson & Johnson) joint research and development exploitation central analgesia medicine, there is opiate receptor agonist and adrenergic transmitter uptake inhibitor dual function, obtain FDA (Food and Drug Adminstration) (FDA) approval listing on November 21st, 2008, be clinically used for releasing in adult to severe acute pain.This product is better tolerance compared with other opium kind analgesics such as morphine (morphine) and tramadol (tramado1), and untoward reaction (such as nausea and vomiting) is lighter.
Universal Chinese character name: tapentadol hydrochloride;
English common name: tapentadol hydrochloride
No. CAS: 175591-09-0
Structural formula:
Tapentadol hydrochloride is the oral analgesic thing acting on central nervous system of a kind of novelty, it has two kinds of mechanism of action: one is to act on opium μ 2 receptor, by improving pain perception and emotional factor, inhibition of pain transmission in spinal cord, thus the activity of the cerebral cortical sites of impact and control perception pain;Another kind is the inhibitory action to norepinephrine reuptake, suppresses its heavy neurocyte that is absorbed into, thus improves the noradrenaline levels in brain, also functions to analgesic activity equally.Tapentadol hydrochloride is independent of metabolism activation effect, does not has metabolism activation product, and various acute inflammations and neuralgia are respectively provided with potent effect, and intravenous injection all can obtain higher blood drug level with oral, is less susceptible to produce analgesic tolerance and dependency compared with morphine.
It has been reported that tapentadol hydrochloride chemical synthesis process have following several.
The synthesis technique (route is as follows) of compound patent EP0693475 report, it is with 3-bromoanisole as initiation material, with 1-(dimethylamino)-2-methyl-3-carbonyl pentane reacts, generate compound 2, the chiral fractionation of compound 2 obtains (1S, 2R)-3-(dimethylamino)-2-methyl isophthalic acid-ethyl-1-(3-methoxyphenyl) propanol (compound 3), compound 3 is through step synthetic hydrochloric acid tapentadol hydrochlorides such as halo, reduction, demethylation, one-tenth salt.The shortcomings such as this process selectivity is poor, and chiral separation yield is low, and atom is uneconomical.Processing step and the above-mentioned technique of patent WO2012023147 report are essentially the same, simply with 2R-1-(dimethylamino)-2-methyl-3-carbonyl pentane reacts with 3-bromoanisole, the isomer of compound 2 reduces 2, splits and becomes simple to operation, but uses R type side chain cost high.
Patent WO2008012047 is with meta-methoxy propiophenone as initiation material, through mannich reaction, fractionation, grignard addition, it is dehydrated, reduces fractionation, demethylation and become salt etc. that tapentadol hydrochloride is synthesized, patent WO2004108658, WO2005000788 all use this technique, compound 3 is esterified by WO2008012283, WO2011067714 by trifluoroacetic anhydride, then reduce, obtain compound 5, it is to avoid partial racemization in compound 3 dehydration, improve yield.This technique initiation material is cheap and easily-available, but during synthesis compound 1, stereo selectivity is poor, needs to improve.Patent WO2008012046 utilizes benzyl protection phenolic hydroxyl group, sloughs protection group simultaneously, eliminate demethylation steps when compound 8 reduces.
Chinese patent CN102002065 reports with under R-proline effect, m-methoxybenzaldehyde and propionic aldehyde occur Andorra to react, one-step synthesis (2R, 3S)-3-hydroxy-2-methyl-3-(3-methoxyphenyl) propionic aldehyde (compound 9), one step builds 2 chiral centres, chiral purity is the highest, have impact on purification yield.
4 diastereomers of method one chiral separation, split difficulty big, and condition requires harshness, and yield is low.Method two uses the method that substep forms chiral centre, needs to split twice, resolution yield about 50% for the first time, and raw material availability is low, uneconomical, needs to improve.Method three occurs Andorra to react under the catalysis of organic micromolecule catalyst L-PROLINE, and a step forms two chiral centres, chiral fractionation, is refining to obtain highly purified (2R, 3R) product, splits 4 isomers 1 time, and yield is substantially reduced.
Asymmetric mannich reaction is the effective means preparing chiral beta-amino acids and amino alcohol and derivant thereof, along with deepening continuously of asymmetric mannich repercussion study, various metallic catalysts and organic micromolecule catalyst are constantly found, and proline is exactly wherein to apply wide organic micromolecule catalyst.Studied L-PROLINE currently without people and be catalyzed asymmetric mannich reaction preparation 2S-3-dimethylamino-1-(3-methoxyphenyl)-2-methyl isophthalic acid-acetone (hereinafter referred to as compound 1), this compound is the key intermediate preparing tapentadol hydrochloride, enantioselective synthesis compound 1 does not only have the highest economic worth, and environmental benefit is also apparent from.
Summary of the invention
The problems such as compound 1 synthesis of selective is low, raw material availability is the highest, three waste discharge is high are present invention mainly solves.
It is an object of the invention to provide the new technology of a kind of enantioselective synthesis compound 1.
Present invention employs following technical proposal:
The invention provides a kind of enantioselective synthesis compound 1 new technology, technical scheme is as follows:
1) with meta-methoxy propiophenone as initiation material, occur asymmetric mannich to react under the catalysis of L-PROLINE, generate compound 1;
2) compound 1 becomes salt refining with L-dibenzoyl tartaric acid, and then dissociating under the conditions of alkalescence obtains high-purity compound 1;
Reaction equation is as follows:
In step 1), meta-methoxy propiophenone, under the catalysis of organic micromolecule catalyst L-PROLINE, occurs asymmetric mannich to react with paraformaldehyde, dimethyl amine, generates compound 1.A kind of in water, methanol, ethanol, oxolane, acetonitrile, the isopropanol of reaction dissolvent or their mixture, preferred solvent is ethanol;Reaction temperature 50-85 DEG C;The rate of charge of L-PROLINE is 0.5~2 equivalents.
Selection process data statistics:
In step 2) in, compound 1 becomes salt refining with L-dibenzoyl tartaric acid, dissociates the most in the basic conditions.Reaction dissolvent is selected from methanol, ethanol, acetone and their mixture, preferably acetone;The rate of charge of L-dibenzoyl tartaric acid is 0.8~1.1.
Selection process data statistics:
Compared to the prior art, the present invention has a following Advantageous Effects:
1) yield is greatly improved, by the technique synthesis compound 1 of document WO2008012047 report, resolution yield about 50%, the lower enantioselective synthesis compound 1 of L-PROLINE catalysis, before refined, ee value reaches more than 92%, after refined, ee value reaches more than 99%, and yield improves to more than 80%, and cost is substantially reduced;
2) according to document it has been reported that process, compound 7 splits in acid condition, and configuration can overturn, be conducive to S anomeric product to generate, but have the product close to half to work as waste material, and the addition of chiral catalyst substantially increases raw material availability, garbage greatly reduces, and environmental benefit is obvious;
3) avoiding the caustic acid such as use concentrated hydrochloric acid, use L-PROLINE to make catalyst, equipment corrosion is few, production operation improvement of environment.
Detailed description of the invention
Further describing technical scheme below by embodiment, for the ordinary skill in the art, the following example does not constitute the restriction to protection scope of the present invention.
Embodiment 1 :
2S-3-dimethylamino-1-(3-methoxyphenyl)-2-methyl isophthalic acid-acetone (compound 1):
In reaction bulb add meta-methoxy propiophenone 262.4g ( 1.6mol), paraformaldehyde 96g(3.2mol), L-PROLINE 92g(0.8mol), dimethylamine 144g(3.2mol), methanol 800ml, stirring and dissolving, is warming up to 65 DEG C of back flow reaction 48 hours, and TLC monitoring raw material is fully converted to product (developing solvent: ethyl acetate: normal hexane=1:3).React complete, be spin-dried for reaction dissolvent, add 10% hydrochloric acid 1300ml and dissolve, the 500ml that adds methylene chloride extracts three times, and organic layer reclaims raw material, and water layer regulates pH value to about 10 with 10% sodium hydroxide 1400ml, add 500mL dichloromethane extraction three times, merge organic layer, be washed to neutrality, anhydrous sodium sulfate is dried, filtering desiccant, filtrate reduced in volume, to without slipping out thing, obtains grease 323.2g, yield 91.4%, ee value 96%.ESI-MS (m/z ) :222 [M+1]+
Refining of compound 1
By compound 1 323.2g (1.46mol), L-dibenzoyl tartaric acid 471.2g(1.32mol) it is dissolved in 2260ml methanol, it is warming up to about 40 DEG C stirring reactions 24 hours, about slow cooling to 5 DEG C, stirs growing the grain 4h, sucking filtration, obtain solid 711g.Solid is dissolved in 2000ml water, and 10% sodium hydroxide regulation pH value, to 9~10, adds dichloromethane 800ml and extracts three times, merge organic layer, be washed to neutrality, and anhydrous sodium sulfate is dried, sucking filtration, is spin-dried for solvent and obtains grease 268.4g, yield 83%.[α]=+ 28.8 ° (C=0.5, methanol), ee value 99.0%. ESI-MS (m/z ) :222 [M+1]+
Embodiment 2 :
2S-3-dimethylamino-1-(3-methoxyphenyl)-2-methyl isophthalic acid-acetone (compound 8):
In reaction bulb add meta-methoxy propiophenone 262.4g ( 1.6mol), paraformaldehyde 96g(3.2mol), L-PROLINE 184g(1.6mol), dimethylamine 144g(3.2mol), ethanol 850ml, stirring and dissolving, is warming up to 77 DEG C of back flow reaction 36 hours, and TLC monitoring raw material is fully converted to product (developing solvent: ethyl acetate: normal hexane=1:3).React complete, be spin-dried for reaction dissolvent, add 10% hydrochloric acid 1300ml and dissolve, the 500ml that adds methylene chloride extracts three times, and organic layer reclaims raw material, and water layer regulates pH value to about 10 with 10% sodium hydroxide 1400ml, add 500mL dichloromethane extraction three times, merge organic layer, be washed to neutrality, anhydrous sodium sulfate is dried, filtering desiccant, filtrate reduced in volume, to without slipping out thing, obtains grease 329.5g, yield 93.2%, ee value 97%.ESI-MS (m/z ) :222 [M+1]+
Refining of compound 1
By compound 1 329.5g (1.49mol), L-dibenzoyl tartaric acid 533.4g(1.49mol) it is dissolved in 2966ml acetone, it is warming up to about 40 DEG C stirring reactions 24 hours, about slow cooling to 5 DEG C, stirs growing the grain 4h, sucking filtration, obtains solid 810.9g.Solid is dissolved in 2500ml water, and 10% sodium hydroxide regulation pH value, to 9~10, adds dichloromethane 1000ml and extracts three times, merge organic layer, be washed to neutrality, and Matrii Sulfas Exsiccatus is dried, sucking filtration, is spin-dried for solvent and obtains grease 306.2g, yield 93%.[α]=+ 29.5 ° (C=0.5, methanol), ee value 99.5%.ESI-MS (m/z ) :222 [M+1]+

Claims (3)

1. a 2S-3-dimethylamino-1-(3-methoxyphenyl) synthesis technique of-2-methyl isophthalic acid-acetone (hereinafter referred to as compound 1), it is characterised in that this technique comprises the following steps:
(1) under the catalysis of L-PROLINE, meta-methoxy propiophenone occurs asymmetric mannich to react with paraformaldehyde, dimethylamine, generates compound 1;
(2) compound 1 becomes salt refining with L-dibenzoyl tartaric acid, the most in the basic conditions the compound 1 of free high chiral purity;
Process route is as follows:
Wherein: L-DBTA represents L-dibenzoyl tartaric acid, (HCHO) n represents paraformaldehyde.
2. according to the preparation method described in claim 1, it is characterized in that: in step 1), meta-methoxy propiophenone is under L-PROLINE is catalyzed, asymmetric Mannich reaction is occurred to generate compound 1, a kind of in water, methanol, ethanol, oxolane, acetonitrile, the isopropanol of reaction dissolvent or their mixture;Reaction temperature is 50-85 DEG C;Catalyst L-PROLINE is 0.5~2 equivalents with the rate of charge of meta-methoxy propiophenone.
3. according to the preparation method described in claim 1, it is characterised in that: in step 2) in, compound 1 and L-dibenzoyl tartaric acid generation salt-forming reaction, reaction dissolvent is selected from methanol, ethanol, acetone and their mixture;L-dibenzoyl tartaric acid is 0.8~1.1 with the rate of charge of compound 1.
CN201510255379.5A 2015-05-19 2015-05-19 A kind of method preparing tapentadol hydrochloride intermediate Pending CN106278915A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510255379.5A CN106278915A (en) 2015-05-19 2015-05-19 A kind of method preparing tapentadol hydrochloride intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510255379.5A CN106278915A (en) 2015-05-19 2015-05-19 A kind of method preparing tapentadol hydrochloride intermediate

Publications (1)

Publication Number Publication Date
CN106278915A true CN106278915A (en) 2017-01-04

Family

ID=57632390

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510255379.5A Pending CN106278915A (en) 2015-05-19 2015-05-19 A kind of method preparing tapentadol hydrochloride intermediate

Country Status (1)

Country Link
CN (1) CN106278915A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101320984A (en) * 2007-06-07 2008-12-10 活元素科技股份有限公司 Communication module with biological magnetic field tuner
CN101495445A (en) * 2006-07-24 2009-07-29 格吕伦塔尔有限公司 Process for the preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
CN101495447A (en) * 2006-07-24 2009-07-29 詹森药业有限公司 Preparation of (2R,3R)-3-(3-methoxyphenyl)-N,N,2-trimethylpentanamine
WO2011083304A1 (en) * 2010-01-05 2011-07-14 Shire Llc Prodrugs of opioids and uses thereof
WO2012023147A1 (en) * 2010-08-16 2012-02-23 Indoco Remedies Limited Process for the preparation of tapentadol

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101495445A (en) * 2006-07-24 2009-07-29 格吕伦塔尔有限公司 Process for the preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
CN101495447A (en) * 2006-07-24 2009-07-29 詹森药业有限公司 Preparation of (2R,3R)-3-(3-methoxyphenyl)-N,N,2-trimethylpentanamine
CN101320984A (en) * 2007-06-07 2008-12-10 活元素科技股份有限公司 Communication module with biological magnetic field tuner
WO2011083304A1 (en) * 2010-01-05 2011-07-14 Shire Llc Prodrugs of opioids and uses thereof
WO2012023147A1 (en) * 2010-08-16 2012-02-23 Indoco Remedies Limited Process for the preparation of tapentadol

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
史兰香等: "脯氨酸催化的直接不对称Mannich 反应", 《河北科技大学学报》 *
马慧等: "盐酸他喷他多的合成", 《中国医药工业杂志》 *

Similar Documents

Publication Publication Date Title
US5733936A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
US6780891B2 (en) Tramadol analogs and uses thereof
US5728885A (en) Method of preparing the enantiomers of O-dimethyltramadol
HU218481B (en) 1-phenyl-3-dimethylamino-propane compounds, pharmaceutical compositions containing them and process for them preparation of the compounds
KR20060036923A (en) Method for the production of substituted 3-aryl-butyl-amine compounds
US8222454B2 (en) Process for preparing optical pure milnacipran and its pharmaceutically accepted salts
KR20070057703A (en) Enantiomerically pure atomoxetine and tomoxetine mandelate
CA2195370C (en) A method of separating the racemate of tramadol
CN106278915A (en) A kind of method preparing tapentadol hydrochloride intermediate
CA2492876C (en) 1-phenyl-2-dimethylaminomethylcyclohexane compounds for therapy of depressive symptoms, pain, and incontinence
AU8238398A (en) Tramadol, salts thereof and process for their preparation
CN103664564B (en) A kind of preparation method of analgesic intermediate compound
EP2545028A1 (en) A novel stereospecific synthesis of (-) (2s,3s)-1-dimethylamino-3-(3-methoxyphenyl)-2-methyl pentan-3-ol
JP2009023978A (en) Method for producing trans-2-benzyloxycyclohexylamine
JP2003510180A (en) Catalysts for asymmetric transfer hydrogenation
EP1785412A1 (en) Tramadol recovery process
CN104151177B (en) A kind of preparation method of tapentadol hydrochloride intermediate
EP1489066B1 (en) Process for production of optically active carboxylic acid
CN105523984B (en) (1R, 2S)- 1- phenyl -2-(1- pyrrolidinyls)The preparation method of -1- propyl alcohol
US9663456B2 (en) Intermediate of tapentadol
WO2015063791A1 (en) Novel process for total synthesis of venlafaxine
KR101675440B1 (en) Method for preparation of optically active 3-amino-arylpropan-1-ol derivatives from 3-chloro-1-arylpropan-1-ol derivatives
CN104355981A (en) Preparation method of tapentadol intermediate methoxypropiophenone
WO2015198108A1 (en) A novel method for synthesis of optically pure beta-amino alcohols
WO2010032254A1 (en) Industrial process for cis(+m-2-r(dimethylamino)-methyl-1-(3- methoxyphenyl) cyclohexanol hydrochloride

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170104

WD01 Invention patent application deemed withdrawn after publication